Literature DB >> 9800643

A rapid reversed phase high performance liquid chromatographic method for the determination of docetaxel (Taxotere) in human plasma using a column switching technique.

M R Rouini1, A Lotfolahi, D J Stewart, J M Molepo, F H Shirazi, J C Vergniol, E Tomiak, F Delorme, L Vernillet, M Giguere, R Goel.   

Abstract

A rapid, simple and sensitive isocratic high performance liquid chromatography (HPLC) method was developed to measure the concentration of docetaxel in plasma samples with UV detection at 227 nm. The method uses a column switching technique with an Ultrasphere C18 column (75 x 4.6 mm ID, 3 mu, Altex, USA) as clean-up column and a CSC-nucleosil C8 column (150 x 4.6 mm ID, 5 mu, CSC, Montreal, Canada) as the analytical column. The mobile phase consisted of Phosphate buffer (30 mM, pH = 3)-acetonitrile (47:53, v/v) with the flow rates of 1.1 and 1.3 ml min-1 for clean-up and analytical columns, respectively. Paclitaxel was used as an internal standard. The plasma samples were extracted using a solid phase extraction method with Ammonium acetate (30 mM, pH = 5)-acetonitrile (50:50, v/v) as final eluent. The extraction method showed a recovery of 92% for docetaxel. In this system, the retention times of docetaxel and Paclitaxel were 7.2 and 8.5 min, respectively. The detection limit of docetaxel in plasma is 2.5 ng ml-1. This analytical method has a very good reproducibility (7.2% between-day variability at a concentration of 10 ng ml-1). It is applicable in clinical and pharmacokinetic studies.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9800643     DOI: 10.1016/s0731-7085(97)00233-1

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  6 in total

Review 1.  Clinical pharmacokinetics of docetaxel : recent developments.

Authors:  Sharyn D Baker; Alex Sparreboom; Jaap Verweij
Journal:  Clin Pharmacokinet       Date:  2006       Impact factor: 6.447

2.  Formulation and pharmacokinetic evaluation of a paclitaxel nanosuspension for intravenous delivery.

Authors:  Yonglu Wang; Xueming Li; Liyao Wang; Yuanlong Xu; Xiaodan Cheng; Ping Wei
Journal:  Int J Nanomedicine       Date:  2011-07-13

3.  Evaluation of the pharmaceutical quality of docetaxel injection using new stability indicating chromatographic methods for assay and impurities.

Authors:  Annarapu Malleswara Reddy; Nagaraju Banda; Shinde Govind Dagdu; Dama Venugopala Rao; Chandra Sekhar Kocherlakota; Vyas Krishnamurthy
Journal:  Sci Pharm       Date:  2010-03-05

4.  Src tyrosine kinase augments taxotere-induced apoptosis through enhanced expression and phosphorylation of Bcl-2.

Authors:  V Boudny; S Nakano
Journal:  Br J Cancer       Date:  2002-02-01       Impact factor: 7.640

5.  Development of RP-HPLC method for simultaneous determination of docetaxel and curcumin in rat plasma: Validation and stability.

Authors:  Dong Wuk Kim; Abid Mehmood Yousaf; Dong Xun Li; Jong Oh Kim; Chul Soon Yong; Kwan Hyung Cho; Han-Gon Choi
Journal:  Asian J Pharm Sci       Date:  2016-08-31       Impact factor: 6.598

6.  Development of a RP-HPLC method for analysis of docetaxel in tumor-bearing mice plasma and tissues following injection of docetaxel-loaded pH responsive targeting polymeric micelles.

Authors:  Moloud Kazemi; Jaber Emami; Farshid Hasanzadeh; Mohsen Minaiyan; Mina Mirian; Afsaneh Lavasanifar
Journal:  Res Pharm Sci       Date:  2020-02-20
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.